Equity Profile

ELAN

Elanco Animal Health Incorporated

Health CarePharmaceuticals$11.2B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Elanco Animal Health Incorporated focuses on developing products for animal health, including vaccines and medications for livestock and pets. As a player in the health care sector, it addresses growing concerns around animal welfare and food safety, which are increasingly important to consumers and regulators alike.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help assess how well Elanco is managing costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, crucial for investor confidence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELAN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+20.15%

Avg Stock Reaction

+9.36%

Last Quarter Recap

In Q1-2026, Elanco reported an EPS of $0.40, surpassing estimates by 16.28%. The stock reacted positively, gaining 13.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are looking for continued strong performance from Elanco, especially after recent earnings surprises. The market will be keen to see if the company can maintain its momentum.

Bull Case

If Elanco continues to beat EPS expectations, it could signal strong operational efficiency and robust demand for its products, potentially leading to further stock price appreciation.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a significant decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Elanco's strong track record of beating EPS estimates, this figure will be crucial for assessing the company's ongoing profitability and market confidence.

How is revenue growth trending in key segments?

Understanding revenue growth in specific product lines will provide insights into the company's market position and future potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Elanco's ability to capitalize on new product launches, which could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

Elanco has consistently beaten EPS estimates, suggesting strong operational performance.

The options market is pricing a move lower than historical averages, indicating potential undervaluation.

Recent trends in animal health spending suggest increased demand that may not be fully reflected in current estimates.

Key Risk

If revenue growth exceeds expectations significantly, it could challenge current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Elanco can sustain its recent earnings momentum and address any growth challenges.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.35 would confirm the bear case, raising concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±9.24%

Historical Avg

±11.3%

Pricing cheap

The options market is pricing in a move of about 9.24%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±9.2% while ELAN has averaged ±11.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

67.6%

Calls (8K)P/C Ratio: 0.17Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elanco beats expectations, history suggests a potential stock increase of around 11.22%, confirming strong operational health.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors weigh management's commentary against expectations.

Miss

If the company misses expectations, history suggests a potential decline of about 3.69%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market demand trends for animal health products.
3Management's commentary on cost management and operational efficiency.
4Guidance for the next quarter and any changes to long-term forecasts.
5Responses to competitive pressures in the animal health market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help assess how well Elanco is managing costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, crucial for investor confidence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELAN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+20.15%

Avg Stock Reaction

+9.36%

Last Quarter Recap

In Q1-2026, Elanco reported an EPS of $0.40, surpassing estimates by 16.28%. The stock reacted positively, gaining 13.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are looking for continued strong performance from Elanco, especially after recent earnings surprises. The market will be keen to see if the company can maintain its momentum.

Bull Case

If Elanco continues to beat EPS expectations, it could signal strong operational efficiency and robust demand for its products, potentially leading to further stock price appreciation.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a significant decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Elanco's strong track record of beating EPS estimates, this figure will be crucial for assessing the company's ongoing profitability and market confidence.

How is revenue growth trending in key segments?

Understanding revenue growth in specific product lines will provide insights into the company's market position and future potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Elanco's ability to capitalize on new product launches, which could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

Elanco has consistently beaten EPS estimates, suggesting strong operational performance.

The options market is pricing a move lower than historical averages, indicating potential undervaluation.

Recent trends in animal health spending suggest increased demand that may not be fully reflected in current estimates.

Key Risk

If revenue growth exceeds expectations significantly, it could challenge current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Elanco can sustain its recent earnings momentum and address any growth challenges.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.35 would confirm the bear case, raising concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±9.24%

Historical Avg

±11.3%

Pricing cheap

The options market is pricing in a move of about 9.24%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±9.2% while ELAN has averaged ±11.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

67.6%

Calls (8K)P/C Ratio: 0.17Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elanco beats expectations, history suggests a potential stock increase of around 11.22%, confirming strong operational health.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors weigh management's commentary against expectations.

Miss

If the company misses expectations, history suggests a potential decline of about 3.69%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market demand trends for animal health products.
3Management's commentary on cost management and operational efficiency.
4Guidance for the next quarter and any changes to long-term forecasts.
5Responses to competitive pressures in the animal health market.